Skip to main content
Optimi Health Corp. logo

Optimi Health Corp. — Investor Relations & Filings

Ticker · OPTI ISIN · CA68405H1001 LEI · 98450063FDFF8UD3Q652 CSE Manufacturing
Open in API
Filings indexed 209 across all filing types
Latest filing 2026-04-25 Share Issue/Capital Cha…
Country CA Canada
Listing CSE OPTI

About Optimi Health Corp.

https://www.optimihealth.ca/

Optimi Health Corp. is a GMP-certified pharmaceutical drug manufacturer and end-to-end drug researcher licensed to produce and supply controlled psychedelic substances. The company specializes in the production of MDMA and psilocybin, primarily supporting psychedelic-based mental health treatments. Additionally, Optimi operates a vertically integrated functional mushroom brand, developing scalable, natural mushroom formulations aimed at the health and wellness sector. This structure allows the company to serve both regulated pharmaceutical supply chains and consumer wellness markets.

Recent filings

Filing Released Lang Actions
Offering document - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a news release announcing the effective date and details of a two-for-one share consolidation, a corporate action that alters the company’s capital structure. This fits the definition of a Share Issue/Capital Change announcement rather than a financing update, regulatory filing, or other category.
2026-04-25 English
Offering document - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a formal offering document detailing the issuance of up to 850,000 new common shares, underwriting arrangements, use of proceeds, and terms of the financing. This is clearly related to the company’s capital raising activity rather than an annual report, earnings release, or corporate governance filing. It describes the structure of the financing, pricing, and use of funds, matching the definition of a Capital/Financing Update.
2026-04-25 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release describing a fund‐raising transaction (an offering of common shares), outlining pricing, regulatory approvals, and closing conditions. It is not the actual prospectus but an announcement of financing activity. This matches the definition for a Capital/Financing Update (CAP).
2026-04-23 English
News release - English.pdf
Regulatory Filings
2026-04-20 English
News release - English.pdf
Regulatory Filings
2026-04-20 English
News release - English.pdf
Regulatory Filings Classification · 0% confidence The document is a corporate press release announcing the launch of a new product initiative (Ibogaine Initiative) and commentary on a U.S. Executive Order. It does not contain financial results, regulatory form references, management changes, capital transactions, or other specific filing content. It is therefore best categorized under the general “Regulatory Filings” fallback for miscellaneous announcements (RNS).
2026-04-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.